EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated SOD1-ALS: A Real-World Multicentre Cohort Study

Andrea Giordano iD, Jessica Mandrioli iD, Federica Cerri iD, Christian Lunetta, Hamidreza Saebfar, Marcella Catania iD, Claudia Battipaglia, Laura Leone, Francesca Trojsi iD, Maria Vizziello iD, Francesca Gerardi, Matteo Farè iD und 11 weitere

International Journal of Molecular Sciences · 09.05.2026 · 27 (10) · 4208

DOI: 10.3390/ijms27104208 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.05.2026. Verfasst von Andrea Giordano und 22 weiteren Autor:innen. Beteiligte Einrichtung: Neurology 3-Neuroalgology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy. Hauptthemen laut MEDLINE: Biomarkers, Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AriSLA, Ministero della salute Ricerca Finalizzata bando 2021, Fondazione Cassa di Risparmio di Modena.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tofersen is a gene-targeted therapy for superoxide dismutase 1 (SOD1)-associated amyotrophic lateral sclerosis (ALS), but neurofilament light chain (NfL) may not fully capture the biological response to treatment. We performed a multicentre retrospective longitudinal study including 24 patients with SOD1-ALS treated with intrathecal tofersen at four Italian referral centres between 2022 and 2025. Cerebrospinal fluid (CSF) and serum biomarkers were assessed at baseline, month 3, month 6, and last available administration using single-molecule array assays to quantify NfL, glial fibrillary acidic protein (GFAP), ubiquitin C-terminal hydrolase L1 (UCHL–1), and total Tau. NfL decreased after treatment initiation in both CSF and serum, providing the clearest pharmacodynamic signal. In contrast, CSF GFAP increased progressively over follow-up, while CSF total Tau and UCHL–1 rose mainly at later timepoints; serum GFAP, total Tau, and UCHL–1 also showed increases during follow-up. ALS Functional Rating Scale–Revised trajectories were broadly stable, whereas disease progression rate was lower at last follow-up than at baseline. Greater reductions in CSF NfL were observed in pathogenic versus uncertain SOD1 variants, and early serum NfL and UCHL–1 changes were associated with longer-term changes in disease progression. These findings suggest that longitudinal multi-analyte profiling may refine biological response stratification beyond NfL alone in tofersen-treated SOD1-ALS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersSuperoxide Dismutase-1Amyotrophic Lateral SclerosisHumansFemaleLongitudinal Studiestau ProteinsUbiquitin ThiolesteraseMaleGlial Fibrillary Acidic ProteinMiddle AgedNeurofilament ProteinsRetrospective StudiesAged

Stichwörter der Autor:innen

GFAPSOD1-ALSUCHL–1cerebrospinal fluidlongitudinal studyneurofilament light chainprecision medicineserum biomarkerstofersentotal Tau

Substanzen

BiomarkersSuperoxide Dismutase-1tau ProteinsUbiquitin ThiolesteraseGlial Fibrillary Acidic ProteinNeurofilament ProteinsSOD1 protein, humanUCHL1 protein, humanneurofilament protein L

Autor:innen und Institutionen

  • Neurology 3-Neuroalgology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Celoria 11, 20133 Milan, Italy.
  • Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Via Vanvitelli 32, 20133 Milan, Italy.
  • Department of Neurosciences, Ospedale Civile Baggiovara, Azienda Ospedaliero Universitaria di Modena, Via Giardini 1355, 41126 Modena, Italy.
  • Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy.
  • NEuroMuscular Omnicentre, Fondazione Serena ETS, Piazza dell'Ospedale Maggiore, 3, 20162 Milan, Italy.
  • Neurorehabilitation Department, Istituti Clinici Scientifici Maugeri IRCCS, Via Camaldoli 64, 20138 Milan, Italy.

ORCID-Profile: Andrea Giordano, Jessica Mandrioli, Federica Cerri, Marcella Catania, Francesca Trojsi, Maria Vizziello, Matteo Farè, Aida Zulueta, Rachele Piras, Giulia Gianferrari, Nilo Riva

Förderung

  • AriSLA
  • Ministero della salute Ricerca Finalizzata bando 2021
  • Fondazione Cassa di Risparmio di Modena
  • Giovanni Marazzina Foundation
  • AriSLA—Fondazione Italiana di ricerca per la SLA
  • Ministero Della Salute

Zitieren

APA

Giordano, A., Mandrioli, J., Cerri, F., Lunetta, C., Saebfar, H., Catania, M., Battipaglia, C., Leone, L., Trojsi, F., Vizziello, M., Gerardi, F., Farè, M., Zulueta, A., Piras, R., Giacchino, M., Gianferrari, G., Dalla Bella, E., Domi, T., Bonanomi, D., …, & Riva, N. (2026). Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated SOD1-ALS: A Real-World Multicentre Cohort Study. International Journal of Molecular Sciences, 27(10), 4208. https://doi.org/10.3390/ijms27104208

Vancouver

Giordano A, Mandrioli J, Cerri F, Lunetta C, Saebfar H, Catania M, et al. Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated SOD1-ALS: A Real-World Multicentre Cohort Study. International Journal of Molecular Sciences. 2026;27(10):4208. doi:10.3390/ijms27104208

BibTeX
@article{Giordano2026,
  author = {Giordano, Andrea and Mandrioli, Jessica and Cerri, Federica and Lunetta, Christian and Saebfar, Hamidreza and Catania, Marcella and Battipaglia, Claudia and Leone, Laura and Trojsi, Francesca and Vizziello, Maria and Gerardi, Francesca and Farè, Matteo and Zulueta, Aida and Piras, Rachele and Giacchino, Matteo and Gianferrari, Giulia and Dalla Bella, Eleonora and Domi, Teuta and Bonanomi, Dario and Ganci, Giuseppe and Lombardi, Raffaella and Lauria, Giuseppe and Riva, Nilo},
  title = {Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-Treated SOD1-ALS: A Real-World Multicentre Cohort Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {10},
  pages = {4208},
  doi = {10.3390/ijms27104208}
}
Kostenlos starten →